Pfizer is betting on gene therapy via external R&D deals with Immusol, Myco, others.

"PFIZERGEN" WILL BE PFIZER BIOTECH R&D COLLABORATION NETWORK for genetic and biotechnology research: Pfizer has entered agreements with Immusol, AEA Technology, Oxford Asymmetry and Myco Pharmaceuticals for joint R&D and for technologies and resources that will enhance internal Pfizer research operations, Pfizer announced March 24.